Innovation Pharmaceuticals Inc (IPIX)

[JB3729]

At the present time, we are trading for less than Prurisol's current value according to this -

For those readers who follow Cellceutix and have been enthusiastic about Kevetrin, this article should help you to see that an acquisition and/or licensing valuation for Cellceutix that is based solely on Prurisol and using Zuckers conservative Prurisol valuation, could be upward of $2.00 per share. Therefore, in my opinion, everyone who buys Cellceutix under $2.00 will have obtained Kevetrin and Dr. Krishna Menon's six other preclinical drugs free.

http://seekingalpha.com/article/932741-valeant-is-on-an-acquisition-spree-will-prurisol-get-under-big-pharma-s-skin

JB